Project Grant R01HL174066
Award Date
9/1/24
Completion Date
8/31/28
Dollars Obligated
$772K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Boston, MA 02115, USA
Similar Awards
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $1,030,417 over 5 years to the Vitalant Research Institute (VRI) to investigate the role of extracellular vesicles (EVs) in the increased risk of cardiovascular disease in people living with HIV (PLWH).
The project aims to characterize the molecular composition and inflammatory properties of EVs derived from PLWH and evaluate...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $123,104 to Emory University to conduct research on the relationships between the HIV reservoir, metabolomics, lipidomics, and subclinical cardiovascular disease (CVD) in persons with HIV, with a focus on examining sex differences. The 5-year award aims to enhance the principal investigator's expertise in multi-omic analyses and...
This $538,800 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will support the "Multiomics and Antiretroviral Drug Exposure for Assessing Metabolic Effects (MADE-FOR-ME)" study at the University of Pittsburgh. The study aims to quantify antiretroviral (ARV) drug exposure and measure cardiovascular disease (CVD) inflammatory biomarkers in specimens from the Multicenter AIDS Cohort...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,485,606 Project Grant (CFDA 93.837 Cardiovascular Diseases Research) to The Johns Hopkins University for the project "Lipoprotein (A) Modification of the Impact of HIV Infection on Atherosclerotic Cardiovascular Disease". The project aims to define lipoprotein(a) (Lp(a)) risk thresholds, explore mechanisms by which Lp(a) is associated with heightened cardiovascular disease risk in people with HIV, and study...
This $771,613 Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will fund a randomized controlled trial to assess the effects of sodium glucose transporter 2 (SGLT2) inhibitors on coronary flow reserve and epicardial adipose tissue volume among women living with HIV. The study aims to identify novel interventions to address the elevated risk of type 2 myocardial infarction in this population. The...
This federal Project Grant award of $2,070,048 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports an investigation of the cellular and molecular mechanisms regulating atherosclerotic plaque stability. The award to The Trustees of Columbia University in the City of New York is focused on understanding the role of macrophages and their interactions with other vascular cells in both plaque stabilization and...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will provide $1,127,798 to The General Hospital Corporation's Research Management Division (doing business as Massachusetts General Hospital) to conduct research focused on understanding the role of macrophages in preserving cardiovascular health and their contributions to cardiovascular disease. The award, effective from February 1, 2025 to...
This Project Grant award, valued at $167,400.00, was provided by the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), to Brigham & Women's Hospital Inc. to conduct research on the role of the immune mediator CD70 in regulating endothelial function and vascular dysfunction.
The key objectives of this research are to:
Elucidate how CD70 regulates endothelial nitric oxide synthase (eNOS) and bioactive nitric oxide...
This federal Project Grant award in the amount of $765,274 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports research to investigate the mechanisms by which defective HIV proviruses in CD4+ T cells and macrophages perpetuate chronic inflammation and contribute to HIV comorbidities, even among patients receiving antiretroviral treatment.
The primary awardee, Boston...
This $472,980 federal Project Grant award was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The primary awardee, Florida International University (FIU), is conducting research to understand the pathophysiological mechanisms and treatment of HIV-associated chronic obstructive pulmonary disease (COPD). The project focuses on determining how HIV and cigarette smoke alter the microRNA regulatory network to...